ERICA ZIMMERMAN: Open Payments
NPI 1922280650 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$272 in 11 payments from 8 companies in 2025. Trend: 2023 $370 · 2024 $668 · 2025 $272
Food & beverage: $272
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $83 |
| Regeneron Healthcare Solutions, Inc. | 2 | $34 |
| Novartis Pharmaceuticals Corporation | 1 | $33 |
| AstraZeneca Pharmaceuticals LP | 1 | $30 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $29 |
| Daiichi Sankyo Inc. | 1 | $26 |
| Eisai Inc. | 1 | $22 |
| Tempus AI, Inc | 1 | $15 |
Products named: Vyloy, LIBTAYO, PLUVICTO, IMFINZI, Nubeqa, Xospata, Enhertu, Lenvima.
Industry payments across TX — which companies pay providers there.
